Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hypromellose 0.3% eye drops
1108010F0AAAAAA
|
Hypromellose | Hypromellose | Eye | 227,191 |
|
Hypromellose 0.5% eye drops
1108010F0AAABAB
|
Hypromellose | Hypromellose | Eye | 21,896 |
|
Hypromellose 0.3% / Dextran '70' 0.1% eye drops
1108010F0AAA4A4
|
Hypromellose | Hypromellose | Eye | 3,758 |
|
Hypromellose 0.32% eye dps 0.5ml unit dose preservative free
1108010F0AABSBS
|
Hypromellose | Hypromellose | Eye | 2,604 |
|
Hypromellose 0.32% eye drops
1108010F0AABNBN
|
Hypromellose | Hypromellose | Eye | 1,206 |
|
Hypromellose 0.3%/Dextran '70' 0.1% eye dps 0.4ml
1108010F0AABXBX
|
Hypromellose | Hypromellose | Eye | 296 |
|
Hypromellose 0.25% eye drops
1108010F0AABZBZ
|
Hypromellose | Hypromellose | Eye | 28 |
|
Hypromellose 0.25% eye drops preservative free
1108010F0AACACA
|
Hypromellose | Hypromellose | Eye | 18 |
|
Hypromellose 1% eye drops
1108010F0AAACAC
|
Hypromellose | Hypromellose | Eye | 18 |
|
Hypromellose 0.5% eye drops preservative free
1108010F0AAALAL
|
Hypromellose | Hypromellose | Eye | 15 |
|
Hypromellose 1% eye drops preservative free
1108010F0AAASAS
|
Hypromellose | Hypromellose | Eye | 3 |
|
Hypromellose 0.32% eye drops preservative free
1108010F0AABYBY
|
Hypromellose | Hypromellose | Eye | 1 |
|
Hypromellose 0.065% eye drops
1108010F0AABQBQ
|
Hypromellose | Hypromellose | Eye | No data available |
|
Hypromellose 0.1% eye drops preservative free
1108010F0AAAXAX
|
Hypromellose | Hypromellose | Eye | No data available |
|
Hypromellose 0.3% eye drops preservative free (drug)
1108010F0AAANAN
|
Hypromellose | Hypromellose | Eye | No data available |
|
Hypromellose 2% eye drops
1108010F0AAADAD
|
Hypromellose | Hypromellose | Eye | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.